173
Views
7
CrossRef citations to date
0
Altmetric
Article

Effect of melatonin on arsenic-induced oxidative stress and expression of MT1 and MT2 receptors in the kidney of laboratory mice

, &
Pages 1216-1230 | Received 25 Dec 2018, Accepted 30 Dec 2018, Published online: 17 Jan 2019

References

  • Acharjee S, Singh SS. 2015. Melatonin and thermal stress regulate differential expression of heat shock proteins and melatonin receptors in spleen of mice. Indian J Pharmaceut Biol Res. 3:36–47.
  • Altikat S, Uysal K, Isa Kuru H, Kavasoglu M, Ozturk GN, Kucuk A. 2015. The effect of arsenic on some antioxidant enzyme activities and lipid peroxidation in various tissues of mirror carp (Cyprinus carpio carpio). Environ Sci Pollut Res. 22:3212–3218.
  • Aust S, Thalhammer T, Humpeler S, Jäger W, Klimpfinger M, Tucek G, Obrist P, Marktl W, Penner E, Ekmekcioglu C. 2004. The melatonin receptor subtype MT1 is expressed in human gall bladder epithelia. J Pineal Res. 36:43–48.
  • Bakirdere S. 2013. Speciation studies in soil, sediment and environmental samples. UK: CRC Press.
  • Bhowmick S, Pramanik S, Singh P, Mondal P, Chatterjee D, Nriagu J. 2018. Arsenic in groundwater of West Bengal, India: a review of human health risks and assessment of possible intervention options. Sci Total Environ. 612:148–169.
  • Brzezinski A. 1997. Melatonin in humans. N Eng J Med. 336:186–195.
  • Bustos-Obregòn E, Poblete D, Catriao R, Fernandes FH. 2013. Protective role of melatonin in mouse spermatogenesis induced by sodium arsenite. Int J Morphol. 31:849–856.
  • Chou S, Harper C, Ingerman L, Lladas F, Colman J, Chappell L, Osier M, Odin M, Sage G. 2007. Toxicological profile for arsenic. US Department of Health and Human Service, Agency for TOXIC substances and Disease Registry, Atlanta, Georgia 30333, USA.
  • Cohen SM, Arnold LL, Eldan M, Lewis AS, Beck BD. 2006. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit Rev Toxicol. 36:99–133.
  • Das K, Samanta L, Chainy GBN. 2000. A modified spectrophotometric assay of superoxide dismutase using nitrate formation by superoxide radicals. Indian J Biochem Biophys. 37:201–204.
  • Dubbels R, Reiter RJ, Klenke E, Goebel A, Schnakenberg E, Ehlers C, Schiwara HW, Schloot W. 1995. Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry. J Pineal Res. 18:28–31.
  • Dutta S, Saha S, Mahalanobish S, Sadhukhan P, Sil PC. 2018. Melatonin attenuates arsenic induced nephropathy via the regulation of oxidative stress and inflammatory signaling cascades in mice. Food Chem Toxicol. doi:10.1016/j.fct.2018.05.032
  • Gordon N. 2000. The therapeutics of melatonin: a pediatric perspective. Brain Dev. 4:213–217.
  • Hadwan MH. 2016. New method for assessment of serum catalase activity. Indian J Sci Technol. 9:80499.
  • Illnerova H, Buresova M, Presl J. 1993. Melatonin rhythm in human milk. J Clin Endocrinol Metab. 77:838–841.
  • Iuvone PM, Brown AD, Haque R, Weller J, Zawilska JB, Chaurasia SS. 2002. Retinal melatonin production: role of proteasomal proteolysis in circadian and photic control of arylalkylamine N-acetyltransferase. Invest Ophthalmol Vis Sci. 43:564–572.
  • Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D, Rhodesd CJ, Valkoc M. 2011. Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol. 31:95–107.
  • Kwak MK, Itoh K, Yamamoto M, Kensler TW. 2002. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol. 22:2883–2892.
  • Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. 1958. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc. 80:2587.
  • Li L, Chen F. 2016. Oxidative stress, epigenetics, and cancer stem cells in arsenic carcinogenesis and prevention. Curr Pharmacol Rep. 2:57–63.
  • Liu F, Ng TB. 2000. Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues. Biochem Cell Biol. 78:447–453.
  • Magalhaes MCF. 2002. Arsenic. An environmental problem limited by solubility. Pure Appl Chem. 74:1843–1850.
  • Mandal BK, Suzuki KT. 2002. Arsenic round the world: a review. Talanta. 58:201–235.
  • Mathes AM. 2010. Hepatoprotective actions of melatonin: possible mediation by melatonin receptors. World J Gastroenterol. 16:6087–6097.
  • Noman ASM, Dilruba S, Mohanto NC, Rahman L, Khatun Z, Riad W, Mamun AA, Alam S, Aktar S, Chowdhury S, et al. 2015. Arsenic-induced histological alterations in various organs of mice. J Cytol Histol. 6:323.
  • Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358.
  • Omar SH, Nabi S. 2010. Melatonin, receptors, mechanism, and uses. Sys Rev Pharm. 1:158–171.
  • Orloff K, Mistry K, Metcalf S. 2009. Bio monitoring for environmental exposures to arsenic. J Toxicol Environ. 12:509–524.
  • Ozturk G, Coskin S, Erbas D, Hasanoglu E. 2000. The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels. Jpn J Physiol. 50:149–153.
  • Parrish AR, Zheng XH, Turney KD, Younis HS, Gandolfi AJ. 1999. Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices. Toxicol Sci. 50:98–105.
  • Reiter RJ. 1996. Functional aspects of the pineal hormone metatonin in combating cell and tissue damage induced by free radicals. Eur J Endocrinol. 134:412–420.
  • Reiter RJ. 1998. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol. 56:359–384.
  • Reiter RJ, Tan DX, Osuna C. 2000. Actions of melatonin in the reduction of oxidative stress. A Review J Biomed Sci. 7:444–458.
  • Reiter RJ, Tang L, Garcia JJ, Mufioz-Hoyos A. 1997. Pharmacological actions of melatonin in free radical pathophysiology. Life Sci. 60:2255–2271.
  • Reppert SM, Weaver DR, Godson C. 1996. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci. 17:100−102.
  • Savaskan E, Wirz-Justice A, Oliveri G, Pache M, Krauchi K, Brydon L, Jokers R, Muller- Sphann F, Meyer P. 2002. Distribution of melatonin MT1 receptor immunoreactivity in human retina. J Histochem Cytochem. 50:519–525.
  • Scher J, Wankiewicz E, Brown GM, Fujieda H. 2002. MT (1) melatonin receptor in the human retina: expression and localization. Invest Ophthalmol Vis Sci. 43:889–897.
  • Shi H, Shi X, Liu KJ. 2004. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem. 255:67–78.
  • Singh SS, Laskar P, Acharjee S. 2015. Age- and sex- dependent effect of exogenous melatonin on expression pattern of melatonin receptor (MT1 and MT2) proteins in spleen of mice. Biol Rhythm Res. 46:403–415.
  • Sinha AK. 1972. Colorimetric assay of catalase. Anal Biochem. 47:389–394.
  • Skwarlo-Sonta K. 2002. Melatonin in immunity: comparative aspects. Neuro Endocrinol Lett. 23(Suppl 1):61–66.
  • Tan DX, Chen LD, Poeggeller B. 1993. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocri J. 1:57–60.
  • Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S, Mayo JC, Sainz RM. 2003. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res. 34:75–78.
  • Tomas-Zapico C, Coto-Montes A. 2005. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res. 39:99–104.
  • Urso ML, Clarkson PM. 2003. Oxidative stress, exercise, and antioxidant supplementation. Toxicology. 189:41–54.
  • Uygur R, Aktas C, Caglar V, Uygur E, Erdogan H, Ozen OA. 2016. Protective effects of melatonin against arsenic-induced apoptosis and oxidative stress in rat testes. Toxicol Ind Health. 32:848–859.
  • Valko M, Morris H, Cronin MT. 2005. Metals, toxicity and oxidative stress. Curr Med Chem. 12:1161–1208.
  • Waalkes MP, Liu J, Ward JM, Diwan LA. 2004. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology. 198:31–38.
  • Yonei Y, Hattori A, Tsutsui K, Okawa M, Ishizuka B. 2010. Effects of melatonin: basic studies and clinical applications. Anti-aging Med. 7:85–91.
  • Zhang Y, Wei Z, Liu W, Wang J, He X, Huang H, Zhang J, Yang Z. 2017. Melatonin protects against arsenic trioxide-induced liver injury by the upregulation of Nrf2 expression through the activation of PI3K/AKT pathway. Oncotarget. 8:3773–3780.
  • Zhao H, Pang SF, Poon AM. 2002. MT1 Receptor-mediated antiproliferative effects of melatonin on the rat uterine antimesometrial stromal cells. Mol Reprod Dev. 61:192–199.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.